INTERNATIONAL PATENT: FRONTIER MEDICINES CORPORATION FILES APPLICATION FOR "PYRIDOPYRIMIDINE DERIVATIVE AS KRAS G12C INHIBITOR FOR THE TREATMENT OF BRAIN METASTASIS"

GENEVA, Sept. 3 -- FRONTIER MEDICINES CORPORATION (151 Oyster Point Blvd., 2nd FloorSouth San Francisco, CA 94080) filed a patent application (PCT/US2025/016654) for "PYRIDOPYRIMIDINE DERIVATIVE AS KRAS G12C INHIBITOR FOR THE TREATMENT OF BRAIN METASTASIS" on Feb 20, 2025. With publication no. WO/2025/179058, the details related to the patent application was published on Aug 28, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): WANG, Yan (c/o Frontier Medicines Corporation151 Oyster Point Blvd., 2nd FloorSouth San Francisco, CA 94080), WEBSTER, Kevin (c/o Frontier Medicines Corporation151 Oyst...